Skip to main content
ARVN logo
ARVN
(NASDAQ)
Arvinas, Inc.
$10.85-- (--)
Loading... - Market loading

Arvinas (ARVN) Stock Price & Financial Analysis

Arvinas Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$10.54 - $11.22
52-Week High$14.51
52-Week Low$5.90
Open$11.05
Volume1.29M
Average Volume (3M)1.29M
Market Cap704.16M
Shares Outstanding64.90M
Price to Sales (P/S)2.80
Price to Book (P/B)1.69
EV/EBITDA-5.68
Revenue (TTM)262.60M
Net Income (TTM)-80.80M
Free Cash Flow (TTM)-275.70M
EPS (TTM)$-1.25
Profit Margin-30.77%
Operating Margin-44.02%
Return on Equity (ROE)-18.62%
Debt to Equity0.02
50-Day MA$12.45
200-Day MA$10.13
52-Week Change61.17%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Arvinas

What is the current stock price for ARVN?

As of the latest trading session, ARVN stock trades at $10.85. The 52-week range is $5.90–$14.51, with a day range of $10.54–$11.22.

What is the P/E ratio for ARVN?

The P/E ratio (Price-to-Earnings) for ARVN is shown in the Key Statistics section. This valuation metric helps compare Arvinas, Inc. to industry peers.

Does ARVN pay dividends?

Arvinas does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ARVN?

Based on 18 analysts, the consensus for ARVN is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ARVN?

Arvinas's market capitalization is $704.2M, classifying it as a small-cap company. Arvinas operates in the Healthcare sector within the Biotechnology industry.